NLM Logo

MB-triple V protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
MB-triple V protocol
Unique ID
C062041
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C062041
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine / *analogs & derivatives
Etoposide
Mitoxantrone
Vincristine
Vindesine
Frequency
1
Note
chemotherapy protocol consisting of mitoxantrone, behenoyl-arabinoside, etoposide, vincrstine & vindesine; used in treatment of acute leukemia
Source
Gan To Kagaku Ryoho 1989;16(12):3729
Date of Entry
1990/01/19
Revision Date
2013/11/06
MB-triple V protocol Preferred
page delivered in 0.005s